Anti-RTN4 / NOGO Reference Antibody (atinumab)
- Product Code: 140450
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in research and therapeutic development for nervous system disorders, particularly in promoting neural regeneration after spinal cord injury. Targets the NOGO (RTN4) protein, which inhibits axonal growth, thereby enabling repair and functional recovery in damaged neural tissues. Investigated in preclinical and clinical studies for treating conditions like multiple sclerosis, stroke, and traumatic brain injury. Also employed as a detection and quantification tool in immunoassays and immunohistochemistry to study NOGO expression in neural tissues.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-RTN4 / NOGO Reference Antibody (atinumab)
Used in research and therapeutic development for nervous system disorders, particularly in promoting neural regeneration after spinal cord injury. Targets the NOGO (RTN4) protein, which inhibits axonal growth, thereby enabling repair and functional recovery in damaged neural tissues. Investigated in preclinical and clinical studies for treating conditions like multiple sclerosis, stroke, and traumatic brain injury. Also employed as a detection and quantification tool in immunoassays and immunohistochemistry to study NOGO expression in neural tissues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :